Stuart Iain 4
4 · VYNE Therapeutics Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Stuart Iain
CHIEF SCIENTIFIC OFFICER
Transactions
- Tax Payment
Common Stock
2025-12-31$0.58/sh−2,448$1,420→ 115,239 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.